Osborn v. The Paul Revere Life Insurance Company

CourtDistrict Court, E.D. California
DecidedMarch 8, 2024
Docket1:21-cv-00842
StatusUnknown

This text of Osborn v. The Paul Revere Life Insurance Company (Osborn v. The Paul Revere Life Insurance Company) is published on Counsel Stack Legal Research, covering District Court, E.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Osborn v. The Paul Revere Life Insurance Company, (E.D. Cal. 2024).

Opinion

1 2

8 IN THE UNITED STATES DISTRICT COURT

9 EASTERN DISTRICT OF CALIFORNIA

11 GORDON R. OSBORN, CASE NO. 1:21-cv-00842-CDB

12 Plaintiff, ORDER GRANTING DEFENDANT’S MOTION FOR SUMMARY JUDGMENT 13 v. (Doc. 29) 14 THE PAUL REVERE LIFE INSURANCE COMPANY, 15 Defendant. 16 17 18 Pending before the Court is the motion for summary judgment by Defendant The Paul Revere 19 Life Insurance Company (“Defendant”), the opposition of Plaintiff Gordon R. Osborn (“Plaintiff”), and 20 Defendant’s reply.1 (Docs. 29-31). For the reasons set forth herein, Defendant’s motion for summary 21 judgment shall be GRANTED. 22 Factual Background2 23 Plaintiff was an oral and maxillofacial surgeon who opened and owned a business in Bakersfield, 24 California. (Doc. 29-2, Joint Statement of Undisputed Facts “JSUF” at ¶ 5). Plaintiff’s job duties

25 1 On June 10, 2021, following the parties’ expression of consent to the jurisdiction of a United States magistrate judge, this action was reassigned to the assigned magistrate judge for all purposes 26 pursuant to 28 U.S.C. § 636(c)(1). (Doc. 7). 27 2 As it must on a motion for summary judgment, the Court sets forth the material facts and draws all reasonable inferences in the light most favorable to Plaintiff, the non-moving party. See Scott v. 28 Harris, 550 U.S. 372, 387 (2007). 1 consisted of third molar surgery, reconstructive jaw surgery, and single and multiple extractions of teeth. 2 (Doc. 30-1, Plaintiff’s Separate Statement of Material Facts “PSMF” at ¶ 93). On March 20, 1989, 3 Plaintiff was issued an individual disability insurance (“IDI”) policy by Defendant, policy number 4 0102385715, and a business overhead expense (“BOE”) policy, policy number 0102385716. (Doc. 29-6 5 at 4, 47; JSUF at ¶ 1). Plaintiff’s IDI and BOE policies begin to pay benefits on the 91st and 31st day of 6 disability, respectively. (JSUF at ¶ 3). The IDI policy provides: 7 “We will periodically pay a Total Disability benefit during Your Total Disability…This benefit 8 will begin on the Commencement Date. We will continue to pay it while You remain Totally Disabled. [] The Paul Revere Life Insurance Company will pay the benefits provided in this 9 Policy for loss due to Injury or Sickness.3 The term Total Disability has been given a particular 10 meaning by the California Department of Insurance. For these policies, it means you are totally disabled when you are rendered unable to perform with reasonable continuity the substantial and 11 material acts necessary to pursue your usual occupation in the usual and customary way. The policy defines Injury as an ‘…accidental bodily injury sustained after the Date of Issue and while 12 Your Policy is in force.’ The policy defines sickness as a ‘sickness or disease which first manifests itself after the Date of Issue and while Your Policy is in force…” 13 14 Id. at ¶ 2 (internal quotations marks omitted). The BOE policy provides for payment of additional 15 benefits due to a claimant’s “Injury” or “Sickness” during a period of “Total Disability” (with those 16 capitalized terms defined identically as defined in the IDI policy):

17 “The amount We will pay is equal to the Covered Monthly Expense You actually incur, while 18 Totally Disabled. … This benefit will begin on the Commencement Date. … Under the BOE 19 policy, Covered Monthly Expense means those fixed, monthly expenses incurred in Your Occupation that are ordinary and necessary in the operation of Your business or profession.” 20 21 Id. at ¶ 4 (internal quotations marks omitted). Plaintiff’s policy benefits, along with premium payments, 22 increased over the years the IDI policy was in force until the promised basic monthly disability benefits 23 totaled $17,400 per month. (PSMF at ¶ 38). Under the terms of the IDI policy, because Plaintiff filed 24 his claim after age 65, his maximum benefit period is 24 months. Id. at ¶ 39. 25 26

27 3 Under the policies, “‘Total Disability’ means that because of Injury or Sickness … You are unable to perform the important duties of Your Occupation.” (JSUF Ex. A, Doc. 29-5 at 15; JUSF Ex. 28 B, Doc. 29-5 at 55) (emphasis added). 1 At some point, Plaintiff was diagnosed with asthma, hypogammaglobulinemia, and hypertension. 2 (JSUF at ¶ 6). On March 8, 2019, Plaintiff was seen by an allergist/immunologist, Rita Kachru, M.D., 3 for a follow-up and evaluation of his allergic rhinitis, asthma, and hypogammaglobulinemia. (PSMF at 4 ¶ 44). Dr. Kachru’s impressions were that Plaintiff’s asthma and allergic rhinitis were well controlled. 5 (PSMF at ¶ 45; Doc. 30-5 at 54). Dr. Kachru also reviewed Plaintiff’s hypogammaglobulinemia. Id. 6 Dr. Kachru advised Plaintiff to continue taking Singulair, Dulera, Azelastine, and Flonase nasal sprays, 7 check his immune status, and obtain laboratory tests prior to following up in a year or earlier as needed. 8 (PSMF at ¶ 45). 9 On March 21, 2019, Plaintiff was seen by David Dougherty, M.D., for an annual physical exam. 10 Id. at ¶ 46. Dr. Dougherty assessed Plaintiff with asthma, hypertension, and essential tremor. (PSMF at 11 ¶ 46; Doc. 30-5 at 64). Dr. Dougherty noted Plaintiff had an exacerbation of asthma in 2018 but had 12 been doing well since. (PSMF at ¶ 46). On December 2, 2019, Plaintiff again saw Dr. Kachru. Id. at ¶ 13 47. Dr. Kachru noted Plaintiff had a history of asthma, hypogammaglobulinemia, and chronic cough. 14 (PSMF at ¶ 47; Doc. 30-5 at 69). 15 On March 5, 2020, Plaintiff again was seen by Dr. Kachru for his annual visit. (PSMF at ¶ 48; 16 Doc. 29-1, Defendant’s Separate Statement of Material Facts “DSMF” at ¶ 7). As with his examination 17 one year earlier (in March 2019), Dr. Karchu found Plaintiff’s allergic rhinitis, asthma, and 18 hypogammaglobulinemia to be well controlled. (DSMF at ¶ 7). “[A]t the time of the pandemic,” Dr. 19 Karchu told patients who had hypogammaglobulinemia or severe asthma that the Centers for Disease 20 Control and Prevention (“CDC”) considered them to be “high risk” and to limit having exposure to 21 anybody who could potentially give them an infection. (Doc. 30-5 at 114). Dr. Karchu provided such 22 general instructions orally to patients with hypogammaglobulinemia. See id. at 113-18 (“Now, again, I 23 apologize. I don’t—I didn’t write it down. I didn’t write it. If you look at anybody’s chart, you’ll see 24 it. It was—a lot of this was verbal unless they needed documentation saying to stay to limit exposure.”). 25 Dr. Karchu observed that “from the pandemic forward, we were very [] particular with our patients with 26 [hypogammaglobulinemia] to ‘[i]f you can, stay home. If you can’t, limit your exposure to sick people. 27 And if you feel like you can’t do it, let me know and I will write you a letter if you need it for your—for 28 your employer.’” Id. at 117. 1 Plaintiff does not recall Dr. Kachru recommending any limitation on his activities or function 2 due to his hypogammaglobulinemia, did not recall discussions with any medical professional about the 3 risk of returning to work in a COVID environment, and no physician ever gave Plaintiff particularized 4 instruction regarding minimizing his COVID risk. (Doc. 31-4 at 19, 23-24).4 5 On March 12, 2020, Plaintiff again was seen by Dr. Dougherty. (DSMF at ¶ 8). Dr. Dougherty 6 found Plaintiff’s blood pressure had been good and controlled. Id. At some point, Dr. Dougherty 7 discussed Plaintiff’s high risk should he catch COVID early in the pandemic. (Doc. 30-5 at 135-36). 8 The record is unclear whether this conversation took place in March 2020 or August 2020. Id. Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Scott v. Harris
550 U.S. 372 (Supreme Court, 2007)
Roberts v. State Farm Mutual Automobile Insurance
61 F. App'x 587 (Tenth Circuit, 2003)
In Re Oracle Corp. Securities Litigation
627 F.3d 376 (Ninth Circuit, 2010)
Santana v. Calderon
342 F.3d 18 (First Circuit, 2003)
United States v. George Dadanian and Jean Dadanian
818 F.2d 1443 (Ninth Circuit, 1987)
Gary Bryant v. Ford Motor Co.
844 F.2d 602 (Ninth Circuit, 1988)
United States v. Roger P. Reetz
18 F.3d 595 (Eighth Circuit, 1994)

Cite This Page — Counsel Stack

Bluebook (online)
Osborn v. The Paul Revere Life Insurance Company, Counsel Stack Legal Research, https://law.counselstack.com/opinion/osborn-v-the-paul-revere-life-insurance-company-caed-2024.